PT1697343E - Aminobenzimidazolos e benzimidazolos como inibidores da replicação do vírus sincicial respiratório - Google Patents

Aminobenzimidazolos e benzimidazolos como inibidores da replicação do vírus sincicial respiratório Download PDF

Info

Publication number
PT1697343E
PT1697343E PT04804949T PT04804949T PT1697343E PT 1697343 E PT1697343 E PT 1697343E PT 04804949 T PT04804949 T PT 04804949T PT 04804949 T PT04804949 T PT 04804949T PT 1697343 E PT1697343 E PT 1697343E
Authority
PT
Portugal
Prior art keywords
aminobenzimidazoles
benzimidazoles
inhibitors
respiratory syncytial
syncytial virus
Prior art date
Application number
PT04804949T
Other languages
English (en)
Inventor
Jean-Francois Bonfanti
Koenraad Jozef Lodewij Andries
Jerome Michel Claude Fortin
Philippe Muller
Frederic Marc Maurice Doublet
Christophe Meyer
Rudy Edmond Willebrords
Tom Valerius Josepha Gevers
Philip Maria Martha Timmerman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of PT1697343E publication Critical patent/PT1697343E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT04804949T 2003-12-18 2004-12-20 Aminobenzimidazolos e benzimidazolos como inibidores da replicação do vírus sincicial respiratório PT1697343E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104797 2003-12-18
US56683404P 2004-04-30 2004-04-30

Publications (1)

Publication Number Publication Date
PT1697343E true PT1697343E (pt) 2009-09-16

Family

ID=34924148

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04804949T PT1697343E (pt) 2003-12-18 2004-12-20 Aminobenzimidazolos e benzimidazolos como inibidores da replicação do vírus sincicial respiratório

Country Status (19)

Country Link
US (1) US8044073B2 (pt)
EP (1) EP1697343B1 (pt)
JP (1) JP4915734B2 (pt)
CN (1) CN1918146B (pt)
AR (1) AR046971A1 (pt)
AT (1) ATE435222T1 (pt)
AU (1) AU2004298457B2 (pt)
BR (1) BRPI0417811A (pt)
CA (1) CA2548657A1 (pt)
DK (1) DK1697343T3 (pt)
ES (1) ES2328700T3 (pt)
MY (1) MY141292A (pt)
NZ (1) NZ547796A (pt)
PL (1) PL1697343T3 (pt)
PT (1) PT1697343E (pt)
RU (1) RU2379302C2 (pt)
TW (1) TWI356055B (pt)
WO (1) WO2005058869A1 (pt)
ZA (1) ZA200605893B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
JP5078887B2 (ja) * 2005-06-20 2012-11-21 テイボテク・フアーマシユーチカルズ 呼吸器シンシチウムウイルスに活性をもつ、1−(2−アミノ−3−(置換アルキル)−3h−ベンズイミダゾイルメチル)−3−置換−1,3−ジヒドロ−ベンゾイミダゾル−2−オン
WO2008077188A1 (en) 2006-12-22 2008-07-03 Avexa Limited Bicyclic pyrimidinones and uses thereof
RU2014137448A (ru) * 2012-02-17 2016-04-10 Эббви Инк. Диаминопиримидины, пригодные в качестве ингибиторов респираторно-синцитиального вируса человека (rsv)
KR102455034B1 (ko) 2013-08-21 2022-10-13 얀센 바이오파마, 인코퍼레이트. 항바이러스 화합물
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
NZ748072A (en) 2017-03-20 2020-06-26 Forma Therapeutics Inc Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US10881666B2 (en) 2017-09-29 2021-01-05 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as RSV inhibitors
EP3594205A1 (en) 2018-07-09 2020-01-15 Abivax Phenyl-n-aryl derivatives for treating a rna virus infection
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
MA53668A (fr) 2018-09-19 2021-09-15 Forma Therapeutics Inc Traitement de la drépanocytose avec un composé activant la pyruvate kinase r

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179505A (en) * 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
WO1995003298A1 (en) 1993-07-19 1995-02-02 Fujisawa Pharmaceutical Co., Ltd. BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
CA2227688C (en) * 1998-01-16 2007-07-31 James W. Critchfield Methods and compositions for inhibition of viral replication
PL200694B1 (pl) * 1999-06-28 2009-01-30 Janssen Pharmaceutica Nv Pochodna benzoimidazolu lub imidazopirydyny, sposób jej otrzymywania i zastosowanie oraz kompozycja farmaceutyczna i sposób jej otrzymywania
ES2228559T3 (es) * 1999-06-28 2005-04-16 Janssen Pharmaceutica N.V. Inhibidores de la replicacion del virus respiratorio sincintial.
DE60008112T2 (de) * 1999-06-28 2004-09-16 Janssen Pharmaceutica N.V. Respiratorisches syncytialvirus replikation inhibitoren
US20040157866A1 (en) * 2001-04-30 2004-08-12 Hisashi Takasugi Amide compounds
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
FR2833948B1 (fr) 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament

Also Published As

Publication number Publication date
AR046971A1 (es) 2006-01-04
ES2328700T3 (es) 2009-11-17
TWI356055B (en) 2012-01-11
EP1697343A1 (en) 2006-09-06
DK1697343T3 (da) 2009-10-05
CN1918146B (zh) 2011-09-14
US20070099924A1 (en) 2007-05-03
CA2548657A1 (en) 2005-06-30
RU2006125726A (ru) 2008-01-27
RU2379302C2 (ru) 2010-01-20
ZA200605893B (en) 2007-11-28
EP1697343B1 (en) 2009-07-01
JP4915734B2 (ja) 2012-04-11
BRPI0417811A (pt) 2007-03-27
TW200602327A (en) 2006-01-16
AU2004298457B2 (en) 2010-05-27
MY141292A (en) 2010-04-16
ATE435222T1 (de) 2009-07-15
WO2005058869A1 (en) 2005-06-30
PL1697343T3 (pl) 2009-12-31
US8044073B2 (en) 2011-10-25
NZ547796A (en) 2009-04-30
AU2004298457A1 (en) 2005-06-30
JP2007514717A (ja) 2007-06-07
CN1918146A (zh) 2007-02-21

Similar Documents

Publication Publication Date Title
ZA200605893B (en) Aminobenzimidazones and benzimidazoles as inhibitors of respiratory syncytial virus replication
TWI349007B (en) Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
EG25799A (en) Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication
HK1103370A1 (en) Respiratory devices and methods of use
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP1827391A4 (en) DOSAGE FORMS AND METHODS OF USE THEREOF
IL189080A0 (en) Substituted benzimidazoles and methods of preparation
IL180488A0 (en) Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof of kinase inhibitors
EP2021455A4 (en) SYSTEM FOR PREPARING CYTOBLOCS AND METHODS OF USE THEREOF
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
EP1951379A4 (en) NOSE OR MOUTH KIT MT THREE OR MORE SKILLS AND MANUFACTURING METHOD THEREFOR
EP1766094A4 (en) INFLUENZA VIRUS VACCINE COMPOSITION AND METHODS OF USE
EP2046413A4 (en) MEDICAL SYSTEMS AND APPLICATION METHOD
EP2023718A4 (en) CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
IL194028A0 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
EP1797186A4 (en) EXPRESSION SYSTEM, ITS COMPONENTS AND USE METHOD
EP1817277A4 (en) PHENYL DERIVATIVES AND METHOD OF USE
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
EP1946007A4 (en) ANDROSTERONE DERIVATIVES AND METHODS OF USE
EP1883404A4 (en) P38 INHIBITORS AND METHODS OF USE
MY142783A (en) 5-or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
EP1768993A4 (en) CYSTEINE-RICH REGION OF SYNCYTIAL RESPIRATORY VIRUS AND METHODS OF USE THEREOF
IL176063A0 (en) Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
SI1723136T1 (sl) Piperidin-amino-benzimidazolni derivati kot inhibitorji replikacije respiratornega sincicijskega virusa
ZA200800536B (en) Substituted benzimidazoles and methods of preparation